Quarterly report pursuant to Section 13 or 15(d)

SUBSEQUENT EVENTS (Details Narrative)

v2.4.0.6
SUBSEQUENT EVENTS (Details Narrative) (USD $)
 0 Months Ended 1 Months Ended 6 Months Ended 66 Months Ended
Apr. 30, 2013
Apr. 16, 2013
Apr. 05, 2013
Mar. 27, 2013
Oct. 05, 2012
Mar. 31, 2013
Mar. 31, 2013
Mar. 31, 2012
Mar. 31, 2013
Description of warrants notification     the Company notified the holders of the Series B warrants, exercisable at $1.19 per share, that it had accelerated the date of expiration of the Series B warrants in accordance with their terms to April 18, 2013. The Company also made an offer to Series B warrant holders that would exercise at least 33% of their warrants to amend the terms of such holders' unexercised Series B warrants (the "Qualified warrants") to provide for (i) an extension of the expiration date of the Qualified warrants to September 30, 2013 ("New Warrant Expiration Date"), (ii) an increase of the exercise price to $2.25, (iii) an acceleration of the New Warrant Expiration Date at the option of the Company following a period of 5 consecutive trading days where the market price per share exceeds 200% of the exercise price then in effect, and (iv) an exercise via a net exercise feature (the Qualified warrants, as amended, referred to as the "Amended Series B warrants")            
Proceeds from warrants exercised for cash     $ 5,060,000     $ 55,481 $ 188,573    $ 4,096,133
Exercise of awards, shares     4,244,984 237,420          
Warrants expired     979,790            
Conversion of Series B Preferred shares to common stock, preferred stock converted   138,889     138,889        
Preferred shares conversion price   1:1              
Conversion of Series B Preferred shares to common stock, common stock   138,889     138,889        
Stock options granted 350,000                
Stock option exercise price $ 1.58                
Stock option vesting terms 87,500 vested upon issuance and the remaining 262,500 vest at 87,500 each year on the anniversary date for the next three years                
Qualified Series B Warrants
                  
Warrants outstanding     6,760,593            
Amended Series B Warrants
                  
Warrants outstanding     6,760,593